Related Experiment Video

Updated: Jul 17, 2026

A Simple Fluorescence-based Reporter Assay to Identify Cellular Components Required for Ricin Toxin A Chain (RTA) Trafficking in Yeast
09:03

A Simple Fluorescence-based Reporter Assay to Identify Cellular Components Required for Ricin Toxin A Chain (RTA) Trafficking in Yeast

Published on: December 15, 2017

Rakicidin A: a hypoxia-selective cytotoxin

Yohko Yamazaki1, Setsuko Kunimoto, Daishiro Ikeda

  • 1Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center, Shizuoka, Japan. yamako@bikaken.or.jp

Biological & Pharmaceutical Bulletin
|February 3, 2007
PubMed

Insights

Researchers discovered rakicidin A, a novel compound with significant hypoxia-selective cytotoxicity. This finding suggests potential for targeted antitumor therapy against solid tumors, offering new hope for cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Microbiology

Background:

  • Hypoxia, a low-oxygen state, is prevalent in solid tumors and drives tumor progression.
  • Hypoxic tumor cells exhibit resistance to conventional therapies like chemotherapy and radiotherapy.
  • Tumor angiogenesis, the formation of new blood vessels, is also linked to hypoxia.

Purpose of the Study:

  • To identify novel hypoxia-selective cytotoxic agents.
  • To evaluate the potential of microbial compounds as targeted cancer therapeutics.

Main Methods:

  • Screening of 20,000 cultured broths from microorganisms.
  • Assessment of cytotoxicity under hypoxic versus normoxic conditions.
  • Evaluation of rakicidin A's interaction with hypoxia-inducible factor 1 (HIF-1) transcriptional activity.

Main Results:

  • Rakicidin A demonstrated significant hypoxia-selective cytotoxicity, being approximately 17.5-fold more potent under hypoxic conditions.
  • The cytotoxicity of rakicidin A under normoxic conditions was unaffected by CoCl2 or antioxidants.
  • Rakicidin A did not inhibit HIF-1 transcriptional activity under hypoxic conditions.

Conclusions:

  • Rakicidin A exhibits promising hypoxia-selective cytotoxicity, suggesting its potential as an antitumor agent.
  • The precise mechanism underlying rakicidin A's hypoxia-selective action remains to be elucidated.
  • This discovery supports the development of selective therapies for solid tumors based on their hypoxic microenvironment.

Related Concept Videos

The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...